Neither adjuvant granulocyte-macrophage colony-stimulating factor (GM-CSF) nor peptide vaccination significantly improved relapse-free or overall survival in patients with high-risk resected melanoma, although GM-CSF may be beneficial in patients with resected visceral metastases, a large phase III trial indicated.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
